Kintegral Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,694
Closed -$1.03M 261
2024
Q1
$1.03M Sell
4,694
-15
-0.3% -$3.3K 0.1% 161
2023
Q4
$1.07M Buy
+4,709
New +$989K 0.12% 151
2022
Q4
Sell
-3,475
Closed -$611K 298
2022
Q3
$611K Hold
3,475
0.08% 189
2022
Q2
$700K Buy
3,475
+74
+2% +$15.8K 0.09% 180
2022
Q1
$770K Buy
3,401
+75
+2% +$17.6K 0.08% 183
2021
Q4
$898K Hold
3,326
0.09% 173
2021
Q3
$804K Hold
3,326
0.09% 171
2021
Q2
$788K Hold
3,326
0.09% 184
2021
Q1
$729K Hold
3,326
0.09% 183
2020
Q4
$582K Hold
3,326
0.08% 196
2020
Q3
$538K Sell
3,326
-107
-3% -$17K 0.08% 193
2020
Q2
$490K Hold
3,433
0.08% 200
2020
Q1
$373K Buy
3,433
+384
+13% +$55.3K 0.07% 209
2019
Q4
$443K Hold
3,049
0.08% 213
2019
Q3
$440K Hold
3,049
0.09% 206
2019
Q2
$453K Hold
3,049
0.09% 206
2019
Q1
$401K Buy
3,049
+1,637
+116% +$202K 0.08% 212
2018
Q4
$153K Buy
+1,412
New +$189K 0.05% 237

Other funds holding LH

Kintegral Advisory's LH Position: Q2 2024 in Review

Kintegral Advisory sold out of Labcorp (LH) in Q2 2024, closing a stake of 4,694 shares — an estimated $1.03M sold.

Kintegral Advisory first reported a position in LH in Q4 2018 and held it in 18 quarters. The position peaked at $1.07M in Q4 2023. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Kintegral Advisory reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Kintegral Advisory sold 4,694 Labcorp shares in Q2 2024, an estimated $1.03M.
  • Kintegral Advisory first reported a position in Labcorp in Q4 2018 and held it in 18 quarters.
  • Kintegral Advisory's Labcorp position peaked at $1.07M in Q4 2023.
  • 854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Kintegral Advisory's 13F filing for Q2 2024, filed 26 Jul 2024.